Norcantharidin inhibits proliferation and promotes apoptosis via c‐Met/Akt/ mTOR pathway in human osteosarcoma cells
Author:
Affiliation:
1. Department of OrthopaedicsThe Fourth People's Hospital of Shaanxi Xi'an Shaanxi China
2. Department of PathologyThe Fourth People's Hospital of Shaanxi Xi'an Shaanxi China
Funder
Launching Scientific Research Fund for Doctors
Publisher
Wiley
Subject
Cancer Research,Oncology,General Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.13900
Reference33 articles.
1. The Epidemiology of Osteosarcoma
2. Molecular mechanisms of chemoresistance in osteosarcoma (Review)
3. Postrelapse Survival in Osteosarcoma of the Extremities: Prognostic Factors for Long-Term Survival
4. Atheroprotective effects and molecular targets of bioactive compounds from traditional Chinese medicine
5. Cantharidin and norcantharidin impair stemness of pancreatic cancer cells by repressing the β-catenin pathway and strengthen the cytotoxicity of gemcitabine and erlotinib
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Norcantharidin Sensitizes Lung Adenocarcinoma Cells to Multitherapy via Targeting the Deregulated Hedgehog Cascade;2024-08-20
2. Serving up health: How phytochemicals transform food into medicine in the battle against cancer;Food Frontiers;2024-07-07
3. Solute carrier family 35 member A2 regulates mitophagy through the PI3K/AKT/mTOR axis, promoting the proliferation, migration, and invasion of osteosarcoma cells;Gene;2024-03
4. Soy isoflavones induces mitophagy to inhibit the progression of osteosarcoma by blocking the AKT/mTOR signaling pathway;Molecular Medicine;2024-01-08
5. Intratumoral injection of norcantharidin liposome emulsion hybrid delivery system amplifies the cancer-fighting effects of oral sorafenib against hepatocellular carcinoma;Colloids and Surfaces B: Biointerfaces;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3